Use of Clobazam for Epilepsy and Anxiety

Summary

This study is an open label, adjunctive, proof of concept, pilot clinical trial. Pediatric patients with epilepsy and clinically significant anxiety will be recruited and if enrolled will receive active treatment, involving flexible dose titration of clobazam and will be monitored for a period of four months. The study will be monitored and overseen by the Johns Hopkins Hospital Institutional Review Board.

Timeline

Start

2017-10-01

Primary completion

2019-12-31

Completion

2019-12-31

Drugs

Indications